套用介紹
急性冠狀動脈綜合徵(ACS)是最詳盡的研究今天臨床實體。在藥物和程式性技術進步在過去三十年已經導致了爆炸的臨床文獻,可以令人生畏的和令人困惑的看守病人心絞痛的症狀。 ACS試驗給你帶來徹底的、專注,md書面總結超過60開創性的試驗,ACS,已經增加了當前的實踐。簡單易用的接口和布局提供快速訪問的俏皮話“語”以及深入的分析和歷史背景的里程碑式的試驗在心臟病學。 每個試驗總結包含: 帶回家的訊息 試驗總結 設計 包含&排除標準 方法 基線患者特點 後續 嗎資金,如果適用 嗎結果 嗎ACC / AHA指南所造成的研究 嗎引用,使用連線到抽象和研究全文 試驗是合適的的名字,出版日期,和主題;可以過濾ACS亞型;並通過一個方便的搜尋特性發現哪些索引關鍵字,通用和品牌,和更多。 這個應用程式還包括一個醫療計算器,由MediMath,對於許多心臟病學相關風險評估工具和公式——從一個fib CHADS2中風的風險評估主動脈瓣區連續性的計算。超過30個計算器被包括。 作者為ACS試驗是西北大學的心臟病和一個內科首席居民,一個的心臟病,和一個:住院醫師在聖路易斯華盛頓大學。他們熱衷於心臟病學和臨床研究和特別注意試驗的背景下,ACC / AHA指南。因此,我們的客戶可以期望頻繁更新的集中ACS試驗。 無論你是一個醫學院學生的出席是問“有什麼證據表明阿司匹林嗎“,一個護士想知道為什麼繼續替滴當支架已經到位,一個心臟病學的人不能記住負荷劑量的ticagrelor或凱斯的確保你對bivalirudin介入之前你大喊大叫,ACS試驗是必備的。 Acute Coronary Syndromes (ACS) are the most exhaustively studied clinical entities today. Advances in pharmacotherapy and procedural technique over the past thirty years have led to an explosion of clinical literature, which can be daunting and confusing for the caretaker of a patient with anginal symptoms. ACS Trials brings you thorough, focused, MD-written summaries of over 60 seminal trials of ACS that have given rise to current practice. Its easy-to-use interface and layout provide quickly accessible one-liner ‘soundbites’ as well as deeper analysis and historical context of landmark trials in cardiology. Each trial summary contains: Take Home Message Trial Summary Design Inclusion & Exclusion Criteria Methods Baseline Patient Characteristics Follow-up Funding, if applicable Results ACC/AHA Guidelines resulting from the study References, with links to the abstract and study full-text Trials are sortable by name, date of publication, and subject; can be filtered by ACS subtype; and are discoverable via a convenient search feature which indexes keywords, generic and brand names, and more. The app also includes a medical calculator, courtesy of MediMath, for many cardiology-related risk assessment tools and formulas -- from the CHADS2 A-fib stroke risk assessment to aortic valve area continuity calculations. Over 30 calculators are included. The writers for ACS Trials are a cardiology fellow at Northwestern University and an internal medicine chief resident, a cardiology fellow, and a hospitalist at Washington University in St. Louis. They are passionate about cardiology and clinical study and pay particular attention to trials in the context of the ACC/AHA Guidelines. As such, our customers can expect frequent focused updates on the trials of ACS. Whether you’re a medical student whose attending is asking “What’s the evidence for aspirin”, a nurse practitioner wondering why to continue the eptifibatide drip when the stent is already in place, a cardiology fellow who can’t remember the loading dose of ticagrelor, or cath fellow making sure you’re right about bivalirudin before the interventionalist yells at you, ACS Trials is a must-have.